SGS Opens Up New Contract Analytical Laboratory for Quality Control Testing in Singapore
SGS celebrated the opening of its new laboratory dedicated to quality control testing of pharmaceuticals, biopharmaceuticals and medical devices. This laboratory expands SGS' Life Science services business international network of currently 16 pharmaceutical Quality Control (QC) operations in North America, Europe and Asia.
"The Singaporean QC laboratory will be a corner stone of our global strategy for the Life Science Services (LSS) group" said Helge Bastian, Executive Vice President LSS. "During the last years, Singapore became a major production hub for pharmaceuticals, biopharmaceuticals and medical devices. Many of our clients in Europe and North America have established manufacturing capabilities there. As their partner, it was a clear decision to expand our network and set up this state-of-the art laboratory. Additionally, we believe the lab can provide services to the vibrant biotechnology community in Singapore, offering testing capabilities and regulatory knowledge that smaller companies might lack."
The new laboratory is located in Ayer Rajah Crescent, close to Biopolis, in the same premises as SGS' current Singaporean operations. The 450 square-metre lab will offer high quality testing capabilities in analytical chemistry, microbiological testing, method development and validation, as well as stability studies. The laboratory was designed with the support and training of European and North American experts, using the vast knowledge of the SGS group. Operations are fully compliant with GMP guidelines ensuring the same high quality standards SGS provides around the world.
Other news from the department manufacturing
